NSE - Delayed Quote INR

Sequent Scientific Limited (SEQUENT.NS)

169.22
+8.09
+(5.02%)
At close: 3:30:01 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Rajaram Narayanan MD, CEO & Director 31.18M -- 1968
Mr. Saurav Bhala Chief Financial Officer 6.52M -- --
Mr. Phillip Trott Assoc. VP, Head of Legal & Chief Risk Officer 840k -- --
Mr. Ramesh Kumar Pillai Corporate Vice President of Ra Qa and Technical Services -- -- 1965
Mr. Ravi Nair Executive Vice President of Human Resources & Administration -- -- --
Mr. Abhishek Singhal Head of Investor Relations -- -- --
Ms. Yoshita Vora Company Secretary & Compliance Officer -- -- --
Mr. Vedprakash Ragate Executive Director -- -- --
Mr. Prasad Lad Vice President of HR & Administration -- -- --

Sequent Scientific Limited

Dosti Pinnacle
301/A, 3rd Floor Plot No. E7, Road No. 22 Wagle Industrial Estate, Thane West
Mumbai, 400604
India
91 22 4111 4777 https://www.sequent.in
Sector: 
Healthcare
Full Time Employees: 
1,195

Description

Sequent Scientific Limited operates in the veterinary healthcare business in Europe, Asia, and internationally. The company provides animal health active pharmaceutical ingredients (APIs) formulations in the areas of anthelmintics, including endo and ecto parasiticides; and anti-protozoal, nutraceuticals, nonsteroidal anti-inflammatory drugs, anti-infectives, and dermatology. It also offers analytical solutions that support API, pharmaceutical, personal care, and nutraceutical organizations; and method validation, stability, and microbiology for APIs and finished products. The company was formerly known as PI Drugs & Pharmaceuticals Ltd. and changed its name to Sequent Scientific Limited in October 2009. The company was incorporated in 1985 and is headquartered in Mumbai, India. Sequent Scientific Limited is a subsidiary of CA Harbor Investments.

Corporate Governance

Sequent Scientific Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

May 20, 2025 at 10:59 AM UTC

Sequent Scientific Limited Earnings Date

Recent Events

September 8, 2021 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers